Prime Minister of Kazakhstan investigates modern scientific advancements at Nazarbayev University

Kazakh Prime Minister Olzhas Bektenov recently met with the Supreme Board of Trustees of Nazarbayev University (NU), Nazarbayev Intellectual Schools, and the Nazarbayev Foundation. The purpose of the meeting was to discuss the state-of-the-art laboratories at NU and the latest scientific developments taking place there, as reported by Bektenov’s press service.

During the meeting, the Supreme Board of Trustees learned about the research teams at NU laboratories who are currently working on projects related to artificial intelligence development, innovations in optoelectronics for green technologies, and advancements in diagnosing and treating complex diseases.

One of the highlights of the meeting was a presentation by Dos Sarbassov, the general director of the National Laboratory Astana (NLA), on his team’s work on developing an effective cancer treatment. He reported encouraging results from initial phases 1 and 2 studies of the drug. Additionally, Ainur Akilzhanova, acting director of NLA’s Center for Life Sciences, discussed creating a “genetic profile” of Kazakh citizens. This genetic profile could help identify predispositions to diseases and contribute to public health protection as well as domestic medicine development in Kazakhstan.

By Samantha Johnson

As a content writer at, I craft engaging and informative articles that aim to captivate readers and provide them with valuable insights. With a background in journalism and a passion for storytelling, I thoroughly enjoy delving into diverse topics, conducting research, and producing compelling content that resonates with our audience. From breaking news pieces to in-depth features, I strive to deliver content that is both accurate and engaging, constantly seeking to bring fresh perspectives to our readers. Collaborating with a talented team of editors and journalists, I am committed to maintaining the high standards of journalism upheld by our publication.

Leave a Reply